Table 1. Representative cDNAs affected in each comparison.
Spot ID | Gene Symbol | Description | AC vs. SC | AE vs. SE | SE vs. SC | AE vs. AC | Int. Spring | Int. Autumn |
1. Thyroid hormone regulations | ||||||||
SB03044B2G04.f1 | APP | Amyloid beta (A4) precursor protein | 1.2 | |||||
SB02006A2H05.f1 | CGA | Glycoprotein hormones alpha chain precursor | −16 (−42.8) | −7.4 (−8.3) | ||||
SB03032A2G07.f1 | CRYM | Mu-crystallin homolog | −2.8 | −2.4 | ||||
SB03046B1C04.f1 | CRYM | Mu-crystallin homolog | −2.7 | −2.1 | ||||
SB03047B2E11.f1 | CRYM | Mu-crystallin homolog | −2.6 | −2.3 | ||||
SB03048B2D08.f1 | HMGN3 | High mobility group nucleosomal binding domain 3 | 1.3 | −1.3 | ||||
SB03037B2H05.f1 | HSPA2 | Heat shock 70 kDa protein 2 | 1.8 | 2 | ||||
SB03044A2D03.f1 | HSPA2 | Heat shock 70 kDa protein 2 | 1.6 | 1.8 (2.4) | ||||
SB02038B2G02.f1 | TTR | Transthyretin precursor | −1.2 | |||||
SB02015A2G08.f1 | TTR | Transthyretin precursor | 13.3 | (−11) | (18.1) | 7 (18.1) | −3.6 (−2.1) | |
SB02026B2H07.f1 | TTR | Transthyretin precursor | 10 | 6.3 | −2.8 | |||
SB02032B2F01.f2 | TTR | Transthyretin precursor | 9.8 | 5.9 | −2.9 | |||
SB03038B1F04.f1 | TTR | Transthyretin precursor | 8.3 | 5.4 | −3 | |||
SB03042A1D05.f1 | VIP | Vasoactive intestinal peptide precursor | −1.5 | |||||
2. Neuroplasticity and transcriptional regulations | ||||||||
SB02032A2C07.f2 | DMAP1 | DNA methyltransferase 1 associated protein 1 | 1.9 | 1.7 | −1.4 | |||
SB03005A2E08.f1 | DNALI1 | Dynein, axonemal, light intermediate chain 1 | 1.2 | |||||
SB02023A1D07.f1 | DYNLL1 | Dynein, cytoplasmic, light chain 1 | 1.3 | |||||
SB02022A2D01.f1 | GADD45B | Growth arrest and DNA-damage-inducible, beta | −2.3 (−2.3) | 2.2 (3.0) | 2.2 (3.0) | 1.2 (2.0) | ||
SB02004A2D01.f1 | MRPL12 | Mitochondrial ribosomal protein L12 | 1.3 | |||||
SB02023A2A01.f1 | MRPS17 | Mitochondrial ribosomal protein S17 | 1.2 | |||||
SB02003A1C05.f2 | NRSN1 | Neurensin 1 | 4.2 | |||||
SB03038A2C12.f1 | PAPD1 | PAP associated domain containing 1 | 1.2 | |||||
SB02016A2E02.f1 | RPL3 | Ribosomal protein L3 (RPL3) | 1.2 | |||||
SB02010B1D10.f1 | RPS6KA2 | Ribosomal protein S6 kinase, polypeptide 2 | 1.4 | −1.3 | ||||
SB02009B1H02.f1 | RPS6KA5 | Ribosomal protein S6 kinase, 90 kDa, polypeptide 5 | −1.4 | |||||
SB03032B1E02.f1 | SMARCAL1 | SWI/SNF, matrix associated, regulator of chromatin | −5.6 | |||||
SB03034B2D05.f1 | ZBTB16 | Zinc finger and BTB domain containing 16 * | −1.6 | 1.9 (2.2) | 1.9 | 1 | ||
SB03036B1C02.f1 | ZBTB16 | Zinc finger and BTB domain containing 16* | −1.4 | 1.7 | 1.7 | 1.1 | ||
3. Cell attachment and filopodial extension | ||||||||
SB02030A2H08.f1 | CDH13 | Cadherin-13 precursor | −1.4 | |||||
SB03003A1F12.f1 | ITGA6 | Integrin, alpha 6 | 1.4 | |||||
SB02022A2D12.f1 | FNBP1L | Formin binding protein 1-like | 1.2 | −1.2 | 1.2 | −1.2 |
Representative cDNA spots significant with cell-means model (p<0.01). Significant fold changes are shown under each pairwise comparison. See tables S1-5 for complete listing. Those in bold were chosen for qPCR validation and significant results (p<0.05) are shown within parenthesis.
ZBTB16 primers were designed outside above EST clone sequences but within sequence annotated as ZBTB16 in zebra finch genome. SC: spring control; AC: autumn control; SE: spring STI; AE: autumn STI; Int: interaction effect (spring: SE vs. SC, autumn: AE vs. AC).